Toll-like receptors and innate antiviral immunity
D. Galiana-Arnoux
UPR9022 CNRS, Institut de Biologie Moléculaire et Cellulaire, 15, rue René Descartes, Strasbourg, France
Search for more papers by this authorCorresponding Author
J.-L. Imler
UPR9022 CNRS, Institut de Biologie Moléculaire et Cellulaire, 15, rue René Descartes, Strasbourg, France
*UPR9022 CNRS Institut de Biologie Moléculaire et Cellulaire 15, rue René Descartes 67000 Strasbourg France Tel: 33 388 417 036 Fax: 33 388 606 922 e-mail: [email protected]Search for more papers by this authorD. Galiana-Arnoux
UPR9022 CNRS, Institut de Biologie Moléculaire et Cellulaire, 15, rue René Descartes, Strasbourg, France
Search for more papers by this authorCorresponding Author
J.-L. Imler
UPR9022 CNRS, Institut de Biologie Moléculaire et Cellulaire, 15, rue René Descartes, Strasbourg, France
*UPR9022 CNRS Institut de Biologie Moléculaire et Cellulaire 15, rue René Descartes 67000 Strasbourg France Tel: 33 388 417 036 Fax: 33 388 606 922 e-mail: [email protected]Search for more papers by this authorAbstract
Viral infections are first detected by a set of innate immunity receptors that detect primary infections by pathogens, and trigger a transcriptional response. Among the induced target genes, type I interferons (IFNs) are central to the antiviral response of the host. The receptors and signaling pathways that mediate the strong induction of the synthesis of these cytokines have long remained elusive. In the past few years, Toll-like receptors (TLRs) emerged as important sensors of infections. Several TLRs participate in the recognition of virus infection, interacting in particular with viral nucleic acids. Upon activation, TLRs interact with different cytosolic adapter molecules and activate transcription factors of the nuclear factor-κB and IFN regulatory factor families that concur to mediate induction of IFN-α/β and other inflammatory cytokines. In addition to the transmembrane TLRs, cytosolic helicases also detect viral nucleic acids, and trigger type I IFN synthesis.
References
- 1 Janeway C. Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989: 54: 1–13.
- 2 Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004: 430: 257–63.
- 3 Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004: 4: 499–511.
- 4 Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999: 284: 1313–8.
- 5 Lemaitre B, Nicolas E, Michaut L, Reichhart J, Hoffmann J. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996: 86: 973–83.
- 6 Medzhitov R, Preston-Hurlburt P, Janeway C. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997: 388: 394–7.
- 7 Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998: 282: 2085–8.
- 8 Jiang Z, Georgel P, Du X et al. CD14 is required for MyD88-independent LPS signaling. Nat Immun 2005: 6: 565–70.
- 9 Alexopoulou L, Holt AC, Medzhitov R, FIavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001: 413: 732–8.
- 10 Lund JM, Alexopoulou L, Sato A et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004: 101: 5598–603.
- 11 Heil F, Hemmi H, Hochrein H et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004: 303: 1526–9.
- 12 Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004: 303: 1529–31.
- 13 Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004: 25: 381–6.
- 14 Omueti KO, Beyer JM, Johnson CM, Lyle EA, Tapping RI. Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 2005: 280: 36616–25.
- 15 Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll- like receptor 5. Nature 2001: 410: 1099–103.
- 16 Yarovinsky F, Zhang D, Andersen JF et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005: 308: 1626–9.
- 17 Zhang D, Zhang G, Hayden MS et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004: 303: 1522–6.
- 18 Kirk P, Bazan JF. Pathogen recognition: TLRs throw us a curve. Immunity 2005: 23: 347–50.
- 19 Cornelie S, Hoebeke J, Schacht AM et al. Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J Biol Chem 2004: 279: 15124–9.
- 20 Rutz M, Metzger J, Gellert T et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 2004: 34: 2541–50.
- 21 De Bouteiller O, Merck E, Hasan UA et al. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 2005: 280: 38133–45.
- 22 Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005: 23: 165–75.
- 23 Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immun 2006: 7: 49–56.
- 24 Lau CM, Broughton C, Tabor AS et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005: 202: 1171–7.
- 25 Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005: 202: 321–31.
- 26 Compton T, Kurt-Jones EA, Boehme KW et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003: 77: 4588–96.
- 27 Tabeta K, Georgel P, Janssen E et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 2004: 101: 3516–21.
- 28 Chen ZJ. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 2005: 7: 758–65.
- 29 Taniguchi T, Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002: 14: 111–6.
- 30 Fitzgerald KA, McWhirter SM, Faia KL et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immun 2003: 4: 491–6.
- 31 Sharma S, TenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003: 300: 1148–51.
- 32 Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 2004: 11: 1060–7.
- 33 Moynagh PN. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol 2005: 26: 469–76.
- 34 Oganesyan G, Saha SK, Guo B et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006: 439: 208–11.
- 35 Hacker H, Redecke V, Blagoev B et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006: 439: 204–7.
- 36 Kufer TA, Fritz JH, Philpott DJ. NACHT-LRR proteins (NLRs) in bacterial infection and immunity. Trends Microbiol 2005: 13: 381–8.
- 37 Edelmann KH, Richardson-Burns S, Alexopoulou L, Tyler KL, Flavell RAO, Idstone MB. Does Toll-like receptor 3 play a biological role in virus infections? Virology 2004: 322: 231–8.
- 38 Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig EF, Iavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004: 10: 1366–73.
- 39 Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004: 103: 1433–7.
- 40 Yang K, Puel A, Zhang S et al. Human TLR-7, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005: 23: 465–78.
- 41 Kato H, Sato S, Yoneyama M et al. Cell type-specific involvement RIG-I antiviral response. Immunity 2005: 23: 19–28.
- 42 Johnson CL, Gale M Jr. CARD games between virus and host get a new player. Trends Immunol 2006: 27: 1–4.
- 43 Ishii KJ, Coban C, Kato H et al. A Toll-like receptor- independent antiviral response induced by double-stranded B-form DNA. Nat Immun 2006: 7: 40–8.
- 44 Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006: 24: 93–103.
- 45 Straight SW, Herman B, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995: 69: 3185–92.
- 46 Barro M, Patton JT. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc Natl Acad Sci USA 2005: 102: 4114–9.
- 47 Yu Y, Wang SE, Hayward GS. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 2005: 22: 59–70.
- 48 Stack J, Haga IR, Schroder M et al. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 2005: 201: 1007–18.
- 49 Andrejeva J, Childs KS, Young DF et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 2004: 101: 17264–9.
- 50 Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immun 2005: 6: 769–76.